Background-Few modifiable behaviors have been identified that are associated with slower rates of functional decline in persons with lower-extremity peripheral arterial disease. We determined whether higher levels of physical activity during daily life are associated with less functional decline in persons with peripheral arterial disease. Methods and Results-The study population included 203 peripheral arterial disease participants who underwent vertical accelerometer-measured physical activity continuously over 7 days and were followed up annually for up to 4 years (mean, 33.6 months). Outcomes were average annual changes in 6-minute walk performance, usual-paced and fast-paced 4-m walking velocity, and the short performance physical battery. Analyses were adjusted for age, sex, race, comorbidities, body mass index, ankle brachial index, smoking, and walking exercise frequency. Higher baseline physical activity levels measured by a vertical accelerometer were associated with significantly less average annual decline in 6-minute walk performance (P for trendϭ0.010), fast-paced 4-m walking velocity (P for trendϭ0.002), and the short performance physical battery (P for trendϭ0.001). Compared with the lowest baseline quartile, those in the highest baseline quartile of physical activity had less annual decline in 6-minute walk performance (Ϫ50.82 versus Ϫ107.0 ft/y; Pϭ0.019), fast-paced 4-m walking speed (Ϫ0.0034 versus Ϫ0.111 m · s Ϫ1 · y Ϫ1 ; Pϭ0.002), and the short performance physical battery (Ϫ0.074 versus Ϫ0.829; Pϭ0.005).
Non-English-speaking patients were excluded because investigators were not fluent in non-English languages. Participants who underwent lower-extremity revascularization after the baseline visit were excluded from analyses after their revascularization.
ABI Measurement
A handheld Doppler probe (Nicolet Vascular Pocket Dop II, Nicolet Biomedical Inc, Golden, Colo) was used to obtain systolic pressures in the right and left brachial, dorsalis pedis, and posterior tibial arteries. 17, 18 Each pressure was measured twice. The ABI was calculated by dividing the mean of the dorsalis pedis and posterior tibial pressures in each leg by the mean of the 4 brachial pressures. 17 Average brachial pressures in the arm with highest pressure were used when 1 brachial pressure was higher than the opposite brachial pressure in both measurement sets and the 2 brachial pressures differed by Ն10 mm Hg in at least 1 measurement set because, in such cases, subclavian stenosis was possible. 17, 18 The lowest leg ABI was used in analyses.
Exertional Leg Symptoms
Participants were categorized into the following leg symptom categories based on previous study 3, 4, 19 : asymptomatic (no exertional leg symptoms), classic intermittent claudication symptoms, leg pain on exertion and rest (exertional leg pain that sometimes begins at rest), exertional leg pain/carry on (exertional leg pain that does not cause the patient to stop walking), and atypical exertional leg pain (exertional leg pain that is not consistent with any of the previous).
Depressive Symptoms
Depressive symptoms were measured annually with the Geriatric Depression Scale Short Form, a 15-item questionnaire assessing the number of depressive symptoms. 20 The Geriatric Depression Scale Short Form score ranges from 0 to 15, with 0 indicating no depressive symptoms and 15 indicating that all depressive symptoms in the Geriatric Depression Scale Short Form are present.
Functional Measures
Functional performance measures were administered at baseline and annually during follow-up.
Six-Minute Walk
Following a standardized protocol, 21, 22 participants walked up and down a 100-ft hallway for 6 minutes after instructions to cover as much distance as possible.
Repeated Chair Rises
Participants sat in a straight-backed chair with their arms folded across their chests and stood 5 times consecutively as quickly as possible. The time to complete 5 chair rises was measured.
Standing Balance
Participants were asked to hold 3 increasingly difficult standing positions for 10 seconds each: standing with feet together side by side and parallel (side-by-side stand), standing with feet parallel with the toes of 1 foot adjacent to and touching the heel of the opposite foot (semitandem stand), and standing with 1 foot directly in front of the other with both feet in a straight line (tandem stand). 23, 24 
Four-Meter Walking Velocity
Walking velocity was measured with a 4-m walk performed at "usual" and "fastest" pace. For the usual-paced walk, participants were instructed to walk at their usual pace "as if going down the street to the store." Each walk was performed twice. The faster walk in each pair was used in analyses. 23, 24 
Short Physical Performance Battery
The short physical performance battery combines data from the usual-paced 4-m walking velocity, time to rise from a seated position 5 times, and standing balance. Individuals receive a score of 0 for each task that they are unable to complete. Scores of 1 to 4 are assigned for remaining tasks based on quartiles of performance for Ͼ6000 participants in the Established Populations for the Epidemiologic Study of the Elderly. 23, 24 Scores are summed to obtain the short physical performance battery score, ranging from 0 to 12.
Physical Activity

Accelerometer-Measured Physical Activity
Physical activity levels were measured objectively and continuously over 7 days with a vertical accelerometer (Caltrac, Muscle Dynamics Fitness Network Inc, Rocklin, Calif). 6, [25] [26] [27] [28] [29] After 7 days, participants reported the number of activity units displayed on the accelerometer by telephone to investigators and mailed their accelerometer back to investigators. We programmed the accelerometer identically for all participants, which allowed us to compare physical activity levels between participants regardless of individual variations in age, weight, height, and sex. 6, 25, 27, 28 Programmed in this way, the accelerometers measured "activity units." 6, 25, 27, 28 This method of measuring physical activity in people with PAD has been validated previously. 6, 8, 25 Because of limited numbers of accelerometers, we distributed them to participants (49%) whenever available.
Patient-Reported Physical Activity Measures
Patient-reported physical activity was measured with a questionnaire derived from the Harvard Alumni Activity Survey that has previously been validated in the Cardiovascular Health Study and the Women's Health and Aging Study. 30 -32 The physical activity questionnaire asked, "During the last week, how many city blocks or their equivalent did you walk? Let 12 city blocks equal 1 mile." It also asked, "In the last week, about how many flights of stairs did you climb up? A flight is 10 steps."
Other Measures
Height and weight were measured at baseline. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared. Education and pack-years of cigarette smoking were determined by patient report. Participants were categorized according to their exercise behavior as follows: no walking for exercise, walking for exercise once or twice per week, or walking for exercise Ն3 times per week.
Follow-Up
Participants were contacted annually for follow-up visits. Final follow-up visits were completed between November 2002 and September 2004. On the basis of previous study, individuals whose data collection forms indicated that they were unable to complete functional measures at follow-up as a result of wheelchair confinement, exhaustion, or other significant symptoms were classified as too disabled to complete functional measures. 4, 16 When no information was provided for the reason that a participant refused to complete functional tests, those who met at least 2 of the following criteria were considered too disabled to walk: The participant reported walking Ͻ5 blocks during the previous week; the score for repeated chair rises equaled 0 or 1; or the score for the standing balance test equaled 0 or 1. The criteria were defined before data analyses. Individuals who refused functional testing at follow-up and met 2 of these criteria were assigned the minimum value for each test not completed. The minimum value for each test was equivalent to the poorest performance among those who completed testing at the corresponding visit.
Statistical Analyses
Baseline physical activity levels for each physical activity measure were categorized into quartiles. The fourth quartile represented the highest activity level. Baseline characteristics between participants who wore vertical accelerometers and those who did not wear vertical accelerometers were compared with general linear models for continuous variables and 2 tests for categorical variables with adjustment for age and sex.
In comparing change in functioning (eg, 6-minute walk distance) across different patient groups, we carried out a longitudinal or repeated-measures ANCOVA using the mixed-effects linear regres-sion analysis. 33 Analyses adjusted for baseline covariates (sex, age, and race) and a time-dependent covariate representing functional performance at the immediately preceding visit were carried out on these successive differences. Similar analyses were repeated with additional adjustment for baseline comorbidities, leg symptoms, education, depressive symptoms, and time-dependent covariates (BMI, ABI, and pack-years of smoking). Associations of accelerometer data with decline in functional performance were analyzed using baseline measures of physical activity. Vertical accelerometer data were not available for most participants at subsequent follow-up visits. In contrast, patient-reported physical activity (stair flights climbed during the past week and blocks walked during the past week) were obtained annually. Therefore, time-dependent analyses were used for analyses of associations of patient-reported physical activity with functional decline. We also performed t test pairwise comparisons for both accelerometer-measured and patient-reported data using participants in the lowest quartile of activity as the reference.
Analyses were repeated among PAD participants who were asymptomatic to determine whether associations were maintained in this subset of PAD participants. To determine whether associations between accelerometer-measured physical activity and functional decline were consistent across levels of functional performance, analyses were repeated after participants were stratified according to tertile for each baseline functional measure.
Mixed-Effects Regression and Handling Missing Data
Associations between physical activity and changes in functional measures were evaluated with mixed-effects models in which a subject-specific random effect is used to account for the potential correlations among successive annual differences in each functional measure of the same participant. Dependent variables in each mixed-effect regression analysis were the successive annual differences in each functional measure. Under this initial mixed-effects regression analysis, statistically valid inference is guaranteed, provided that missing data caused by patient dropout are unrelated to unobserved data (ie, any missing data are missing at random). As a safeguard against violations to this assumption that missing data are missing at random, we repeated the fully adjusted comparisons using a repeated-measures pattern-mixture ANCOVA model. 34, 35 Because data were analyzed using successive differences, multiple patterns of missing differences were observed in our analyses. The different patterns of missing data were included as 2 binary indicator covariates (centered about their means). By including patterns of missing data in analyses as centered covariates and averaging over these patterns using adjusted least-squares means, one can obtain an unbiased estimate of the marginal means adjusted for covariates. 35 Analyses were performed with SAS statistical software (version 9.1, SAS Institute Inc, Cary, NC).
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
Four hundred sixty participants with PAD completed baseline testing in the WALCS. Of these 460 participants, 26 died or were lost to follow-up before the first follow-up visit, and 17 underwent lower-extremity revascularization before their first follow-up visit and were excluded from analyses, leaving 417 PAD participants for analyses. Of these 417, 203 had baseline vertical accelerometer data. As shown in Table 1 , no significant differences were found in characteristics of participants who wore the accelerometer and those who did not. Table 2 shows characteristics of the study population across quartiles of accelerometer-measured physical activity levels. Higher baseline physical activity was associated with more blocks walked during the past week, higher ABI values, lower Geriatric Depression Scale Short Form scores, and better performance on each measure of lower-extremity functioning at baseline. Adjusting for age, sex, race, ABI, BMI, smoking, leg symptoms, comorbidities, missing data patterns, education, and depressive symptoms, we observed significant, graded associations between accelerometer-measured physical activity at baseline and average annual decline in 6-minute walk performance, fast-paced walking velocity, and the short performance physical battery (Figure 1 ). Compared with participants in the lowest baseline quartile of physical activity, PAD participants in the third quartile of physical activity had less decline in the usual-paced 4-m walking velocity (Pϭ0.017), fast-paced 4-m walking velocity (Pϭ0.001), and short performance physical battery (PϽ0.001). Compared with participants in the lowest baseline quartile of physical activity, those in the highest (fourth) quartile had less decline in 6-minute walk performance (Pϭ0.019), fast-paced walking speed (Pϭ0.002), and short physical performance battery (Pϭ0.005).
Among the 39 asymptomatic PAD participants who wore vertical accelerometers at baseline, those who were more physically active had significantly less decline in 6-minute walk performance and in usual-and fast-paced walking velocity (Figure 2) .
We repeated the analyses after stratifying participants according to tertiles of baseline functional performance ( Table 3 ). Within these tertiles, significant associations between accelerometer-measured physical activity and average annual functional decline were observed among participants in either or both of the lowest or middle tertiles of baseline perfor- mance for all measures except usual-paced 4-m walking velocity. Thus, higher physical activity during daily life may be of greatest benefit to PAD persons with greatest functional limitation. Table 4 shows associations between time-dependent patient-reported physical activity and average annual functional decline. After adjustment for age, sex, race, prior year's performance, ABI, BMI, smoking, leg symptoms, comorbidities, missing data patterns, education, and depressive symptoms, more blocks walked during the previous week were associated with less average annual decline in the short performance physical battery (P for trendϭ0.004). More stair flights climbed during the previous week were associated with less decline in the usual-paced (P for trendϭ0.010) and fast-paced (P for trendϭ0.022) 4-m walking velocities.
Discussion
Among people with PAD, higher levels of physical activity during daily life, measured over 7 days with a vertical accelerometer, were associated with significantly less average annual decline in objectively measured functional performance at the 4-year follow-up compared with lower baseline levels of physical activity. Results also suggest that persons with PAD who have greatest functional impairment may benefit most from higher physical activity levels. Significant associations of higher physical activity with less functional decline also were observed within the subset of participants with asymptomatic PAD. To the best of our knowledge, no prior studies have reported associations between physical activity during daily life and functional decline in people with PAD. No medications are approved by the Food and Drug Administration for improving walking performance in persons with asymptomatic PAD, 36 despite the previously established finding that persons with PAD who are asymptomatic are at particularly high risk of functional decline. 4 Although supervised treadmill exercise programs significantly improve walking performance in people with intermittent claudication, 9, 37 barriers such as cost and transportation limit access to exercise rehabilitation programs for most people with PAD. 10, 11 Thus, few persons with PAD participate in supervised exercise programs. 11 Identifying modifiable behaviors associated with slower rates of functional decline provides new opportunities that are noninvasive and inexpensive for preserving lower-extremity performance in people with PAD.
Several mechanisms may explain the relative preservation of lower-extremity functional performance in persons with PAD who are more physically active during daily life.
First, in persons without PAD, higher levels of physical activity may reduce systemic atherosclerosis by improving risk factors like hypertension, hyperlipidemia, and diabetes. 38 If higher rates of physical activity during daily life slow the progression of lower-extremity atherosclerosis, that may explain findings presented here. Second, in persons without PAD, physical activity is associated with improved peripheral arterial endothelial function and increased lower-extremity blood flow. 39 -43 Third, physical activity may improve metabolic efficiency and improve oxygen extraction within the muscle tissue. 44, 45 Fourth, increased levels of physical activity could favorably alter gait, resulting in more efficient walking techniques. 46, 47 Finally, higher physical activity levels are inversely associated with inflammatory markers in persons with PAD. 48 These physiological and metabolic changes associated with physical activity may explain the association of higher physical activity with slower functional decline among persons with PAD. However, further study is needed. Patient-reported measures of physical activity were less strongly associated with rates of functional decline compared with associations of the vertical accelerometer measure with functional decline. Objective measures of physical activity are likely to be more accurate than patient-reported physical activity levels.
This study has limitations. Only 49% of participants wore the vertical accelerometer device because of the limited availability of these monitors for study participants. However, no differences in baseline characteristics were found between participants who wore the accelerometer and those who did not. Second, these data are observational. Associations of lower levels of physical activity with greater functional decline cannot be construed as causal. Although we adjusted for confounders including comorbidities, we cannot rule out the possibility that residual confounding, unidentified characteristics, or greater illness severity among participants with lower physical activity levels contributed to the observed differences in functional decline across physical activity groups. Third, we did not collect data on intensity of physical activity.
Conclusions
Persons with PAD with higher levels of physical activity during daily life had less annual decline in objectively measured functional performance measures at 4-year follow-up. These findings suggest that physicians should encourage patients with PAD to increase their daily physical activity levels because higher physical activity may protect against functional decline. On the basis of our findings, physicians should encourage their PAD patients to increase activity within their homes, to choose stairs rather than the escalator or elevator, and to walk rather than drive when traveling short distances. Future study with a clinical trial is necessary to determine whether interventions that increase physical activity levels reduce rates of functional decline in patients with PAD.
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